gobal chemicals trading platform prosessional chemical database
look for chemicals? Go >
Sign In
|
Join Free
|
Details
|
PDF
|
Products
|
Make Me Home Page
|
Add to favorite
Products
Details
PDF
About Us
Current position:
Home
>
Products
>
Lunacalcipol
Lunacalcipol
CAS Registry Number:
250384-82-8
Synonyms:
Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
Molecular Formula:
C28H42O4S
Molecular Weight:
474.7
EINECS:
Melting Point:
Solubility:
The Complete List of Suppliers for Lunacalcipol
Hot Products
Decanedinitrile, 2-octyl-, reaction products with ammonia and hydrogen
Z-oxylysine
Propanamide,3-[(4R,5Z)-3,4-dihydro-4- (methylamino)benz[cd]indol-5(1H)-ylidene]-2- methyl-N-[(2R,5S,10aS,10bS)-2,3,5,6,9,10,10a,- 10b-octahydro-10b-hydroxy-2-(1-methylethyl)- 3,6-dioxo-5-(phenylmethyl)-8H-oxazolo[ 3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-,(2S)-
1,3-bis(benzylideneamino)urea
ethyl [2-(ethenyloxy)ethyl]dithiocarbamate
1-Benzocyclobutenecarbonitrile
5,5-dimethyl-2-oxotetrahydrofuran-3-carbonitrile
Hexanedioic acid, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, butanediol and 1,1-methylenebis(4-isocyanatocyclohexane)
4-(benzylsulfanyl)benzoic acid
3-[6-(4-bromophenyl)imidazo[2,1-b][1,3]thiazol-3-yl]-6-chloro-2-methyl-4H-chromen-4-one
sodium (Z)-5-fluoro-2-methyl-1-[[4-(methylsulphinyl)phenyl]methylene]-1H-indene-3-acetate
Alcohols, tallow, propoxylated
N-[(3-methoxyphenyl)carbamothioyl]biphenyl-4-carboxamide
S-[naphthalen-1-yl(diphenyl)methyl]cysteine
2,3-dimethylthiirane 1,1-dioxide
Trispiro[furan-2(3H),2'-[2H]cyclopenta[b]furan-5'(3'H),12''(2''H)-furo[3'',2'':3',4']cyclopenta[1',2':5,6]naphth[1,2-b]indeno[4,5-i]phenazine-2'',2'''(3'''H)-furan]-11''(1''H)-one,3'a,3''a,4,4',4'',4''',4''a,4''b,5,5'',5''',6',6'',6'a,6''a,7'',9'',9''a,9''b,10'',12''a,13'',14'',14''a,15'',17'',17''a,17''b,18'',19'',19''a,19''b-dotriacontahydro-4',19''-dihydroxy-1'',3',4',5,5,5''',5''',9''a,17''a,19''a-decamethyl-,(1''S,2R,2''R,3'S,3'aS,3''aS,4'S,4''bR,5'R,6'aS,6''aS,9''aS,9''bS,12''aR,14''aS,17''aS,17''bS,1
About us
|
Service
|
Link
|
Add to favorite
©2010 EaseChem.com
![250384-82-8,Lunacalcipol,Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol](http://www.lookchem.com/300w//file1.lookchem.com/cas/2024/01/08/250384-82-8.jpg)